FFA
CADL icon

Farther Finance Advisors’s Candel Therapeutics CADL Stock Holding History

Farther Finance Advisors’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206 Buy
+20
New +$151 ﹤0.01% 5713

Other funds holding CADL

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LF
LifeSteps Financial Claremont, California $215M AUM 27.52% 1-Year Est. Return

Farther Finance Advisors's CADL Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in Candel Therapeutics (CADL) in Q2 2026: 20 shares worth $206. The stake represents ﹤0.01% of the portfolio and ranks #5713 among its holdings.

6 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Farther Finance Advisors held 20 shares of Candel Therapeutics worth $206 as of Q2 2026.
  • Candel Therapeutics was a new Farther Finance Advisors position in Q2 2026.
  • Candel Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5713 holding.
  • 6 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.